[1]
J. Luo, “Dynamic evaluation of liver fibrosis to assess hepatocellular carcinoma risk in patients with chronic hepatitis B receiving nucleoside analogs treatment”, Rev. Inst. Med. Trop. São Paulo, vol. 66, p. e27, May 2024, doi: 10.1590/.